NCT01713634

Brief Summary

Bone loss is not only a well-documented effect of spaceflight on astronauts, but also a condition that affects millions of men and women on Earth each year. Many countermeasures to bone loss have been proposed, and many have been evaluated to some degree. To date, those showing potential have focused on either exercise or pharmacological interventions, but none have targeted dietary intake alone as a factor to predict or minimize bone loss during spaceflight. The investigators proposed to document how the ratio of acid precursors to base precursors in the diet is related to directional changes in markers of bone resorption and formation during flight and recovery from flight. There is a high likelihood for success in predicting the extent of bone loss from dietary intake patterns of astronauts during spaceflight, given that this concept is strongly anchored in data obtained from ground-based experiments in our laboratory and others. The notion of manipulating diet to minimize bone loss could also have significant social and economic impacts for NASA and for the general public - especially given the increasing trends for diets that are high in animal protein and low in fruits and vegetables. The results of the proposed experiments will lead to development of a dietary countermeasure for bone loss consisting of a balanced diet with no associated risks for side effects that might be present with pharmaceuticals or supplements, no requirement for payload mass, and no additional crew time necessary during flight.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
17

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2009

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2009

Completed
3.8 years until next milestone

First Submitted

Initial submission to the registry

October 19, 2012

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 25, 2012

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2015

Completed
Last Updated

November 16, 2015

Status Verified

November 1, 2015

Enrollment Period

6.8 years

First QC Date

October 19, 2012

Last Update Submit

November 13, 2015

Conditions

Keywords

Bone resorptionDiet

Outcome Measures

Primary Outcomes (9)

  • Change in urinary n-telopeptide after 15 days of space flight compared to preflight

    24-h NTX will be used as an indicator of bone resorption

    15 days

  • Change in urinary n-telopeptide after 30 days of space flight compared to preflight

    30 days

  • Change in urinary n-telopeptide after 60 days of space flight compared to preflight

    60 days

  • Change in urinary n-telopeptide after 120 days of space flight compared to preflight

    120 days

  • Change in urinary n-telopeptide after 180 days of space flight compared to preflight

    180 days

  • Change in urinary calcium after 15 days of space flight compared to preflight

    15 days

  • Change in urinary calcium after 60 days of space flight compared to preflight

    60 days

  • Change in urinary calcium after 120 days of space flight compared to preflight

    120 days

  • Change in urinary calcium after 180 days of space flight compared to preflight

    180 days

Secondary Outcomes (1)

  • Change in urinary calcium after 30 days of space flight compared to preflight

    30 days

Study Arms (2)

Low Apro/K Diet

EXPERIMENTAL

Subjects consume a prescribed diet for 4 days with a low ratio of animal protein to potassium (0.3-0.6 g/mEq).

Other: PreflightOther: In-flight

High Apro/K Diet

EXPERIMENTAL

Subjects consume a prescribed diet that has a high ratio of animal protein to potassium (1.0-1.3 g/mEq) for 4 days.

Other: PreflightOther: In-flight

Interventions

4-d controlled diet sessions will occur twice before flight.

High Apro/K DietLow Apro/K Diet

4-d controlled diet sessions will take place on flight days 15, 60, 120, and 180. Flight day 30 will only be monitored intakes (subject consume nominal intake)

High Apro/K DietLow Apro/K Diet

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Astronauts flying on long-duration (3-6 months) spaceflights

You may not qualify if:

  • Non-astronauts

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Johnson Space Center

Houston, Texas, 77058, United States

Location

Related Publications (3)

  • Zwart SR, Hargens AR, Smith SM. The ratio of animal protein intake to potassium intake is a predictor of bone resorption in space flight analogues and in ambulatory subjects. Am J Clin Nutr. 2004 Oct;80(4):1058-65. doi: 10.1093/ajcn/80.4.1058.

    PMID: 15447920BACKGROUND
  • Zwart SR, Davis-Street JE, Paddon-Jones D, Ferrando AA, Wolfe RR, Smith SM. Amino acid supplementation alters bone metabolism during simulated weightlessness. J Appl Physiol (1985). 2005 Jul;99(1):134-40. doi: 10.1152/japplphysiol.01406.2004. Epub 2005 Feb 3.

    PMID: 15691900BACKGROUND
  • Zwart SR, Rice BL, Dlouhy H, Shackelford LC, Heer M, Koslovsky MD, Smith SM. Dietary acid load and bone turnover during long-duration spaceflight and bed rest. Am J Clin Nutr. 2018 May 1;107(5):834-844. doi: 10.1093/ajcn/nqy029.

MeSH Terms

Conditions

Bone Resorption

Condition Hierarchy (Ancestors)

Bone DiseasesMusculoskeletal Diseases

Study Officials

  • Scott M Smith, PhD

    National Aeronautics and Space Administration (NASA)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
FED
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Manager for Nutritional Biochemistry

Study Record Dates

First Submitted

October 19, 2012

First Posted

October 25, 2012

Study Start

January 1, 2009

Primary Completion

November 1, 2015

Study Completion

November 1, 2015

Last Updated

November 16, 2015

Record last verified: 2015-11

Locations